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Human rabies can manifest as two clinical forms: furious 
(encephalitic) or dumb (paralytic) rabies. Paralysis of 
limbs and respiratory muscles occurs in furious rabies 
patients only when they become obtunded, whereas 
weakness is clinically evident as the dominant pre- 
senting feature in dumb rabies patients.’ We report a 
fully conscious patient with furious rabies who rapidly 
developed total limb and facial paralysis soon after 
receiving intravenous human rabies immune globulin 
(RIG). 
A 26-year-old-female patient was admitted to 
Chulalongkorn University hospital with a history of dog 
bite to the right leg 2 months previously. She did not 
receive pre- or post-exposure rabies prophylaxis. One 
day prior to admission, she developed fever and was 
restless, with neuropathic pain in the right leg. On 
examination, she exhibited phobic spasms but remained 
conscious and rational. There was no demonstrable 
weakness of limbs and facial muscles. Sensory functions 
and deep tendon reflexes were intact. Twenty-five grams 
of human RIG (150 IU/mL with a protein content of 
16.5+1.5%, National Blood Bank, Thai Red Cross 
Society) was administered intravenously 2 h after 
admission. The second and third doses of 25 g were 
infused at 12-h intervals. The last dose was given 24 h 
after the third one. Thirty-six hours after the first dose, 
the patient, while remaining alert, had pure motor weak- 
ness of all limb and neck flexor muscles of 3/5 MRC 
grade. This was accompanied by fasciculations. Severe 
bilateral facial palsy also became apparent. Extraocular 
muscle function remained intact, but the pupils became 
fixed and dilated. Deep tendon reflexes were absent, 
except for a +l reaction of the biceps. Total opthalmo- 
plegia and limb and respiratory paralysis requiring 
ventilatory support ensued within the following 6 h. 
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However, communication was still possible by nodding 
or by movement of the fingers. Severe congestive 
heart failure developed on the same day (second day 
of hospitalization). Left ventricular ejection fraction 
(LVEF) was found to be 29%. The cardiac index (CI) 
was 2.3 L/min per m2, with a pulmonary capillary wedge 
pressure (PCWP) and systemic vascular resistance index 
(SVRI) of 15 mmHg and 1864 dyne s cm-5 respectively. 
Cardiac-specific troponin T was detectable, and the 
creatine kinase-MB (CK-MB) level was 91 units, with a 
ratio of CK-MB/total CK of 8.4% (the normal value 
is less than 5%). One gram of pulse methylprednisolone 
was given for 4 consecutive days, starting on day 3 after 
admission for suspected myocarditis, along with 
supportive care for heart failure. The patient was 
hemodynamically stable within 48 h (an LVEF of 44%, 
a CI of 3.2 Wmin per m2, a PCWP of 12 mm Hg, and an 
SVRI of 1567 dyne s cm”), and remained so throughout 
the rest of her clinical course. She also remained con- 
scious and obeyed commands until day 6, when she 
lapsed into a coma. She remained in a vegetative state 
for the next 8 days. The total clinical course after the 
onset of symptoms was 15 days. Rabies RNA could 
be detected in the saliva on days 2, 3 and 7, and in 
the cerebrospinal fluid (CSF) on day 3 after the onset 
of symptoms (patient 3 in Wacharapluesadee and 
Hemachudha2). Postmortem examination revealed the 
widespread presence of Negri bodies in the brain and 
spinal cord. Inflammatory reactions were also seen in 
corresponding regions and in spinal nerve roots and 
myocardium. Myocardial necrosis was not extensive. 
It has been previously shown that treatment of 
rabies virus-infected rats with monoclonal virus-neutral- 
izing antibodies injected intramuscularly prevents lethal 
disease and promotes clearance of the virus from the 
central nervous system (CNS).3 The precise mechanism 
is not known. Our previous magnetic resonance imaging 
studies of rabies patients showed that gadolinium con- 
trast enhanced abnormalities in several regions, in- 
cluding brainstem, thalamus, basal ganglia, and spinal 
nerve roots, suggesting damage to the blood-brain and 
blood-nerve barriers.4 The dosage of rabies-specific 
human immune globulin administered to our patient 
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was similar to that given to patients with autoimmune 
conditions such as Guillain-Barre syndrome. Neverthe- 
less, on day 3 after admission, rabies RNA was not 
cleared from the CSE We were never able to detect any 
rabies-neutralizing antibodies in spinal fluid, suggesting 
that RIG could not pass the blood-brain barrier. 
Although the survival period in our patient was longer 
than expected in a patient with furious rabies (average 
5 days), and what appeared to have been myocarditis 
could be controlled, the neurologic deterioration could 
not be halted. Clinical transformation from the furious 
to the dumb form after intravenous human RIG treat- 
ment is intriguing. An ‘innocent bystander’ mechanism 
has been proposed, based on the finding of deposition of 
IgG and complement on rabies virus-positive axons in a 
Chinese paralytic rabies patient.5 However, this remains 
obscure without the presence of CSF rabies antibody. 
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